Endocardial Solutions
Saint Paul
About Endocardial Solutions
Endocardial Solutions, Inc. ("ESI" or the "Company") designs, develops, and manufactures a minimally invasive diagnostic system that diagnoses, within the span of a few heartbeats, tachycardia, a potentially fatal abnormal heart rhythm. The Company believes that its proprietary EnSite catheter and clinical workstation (together, the "EnSite System") is a powerful new diagnostic tool that will enable electrophysiologists to rapidly and comprehensively map tachycardia and improve the selection of patient treatment options.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 101 – 250
- Total funding: $12.7M
- Funding stage: M&A
- Last round: Post-IPO Equity (Jun 2000)
- Ticker: nasdaq:ECSI
- Website: endocardial.com
- Phone: (651)523-6900
Industries & Categories
Health Care, Health Diagnostics, Manufacturing
Canonical: https://fsome.com/organization/endocardial-solutions-684633 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.